NASP data highlight reduction in disease burden among people living with uncontrolled goutGamifant (emapalumab) data showed response rates in ...

High uric acid levels, or hyperuricemia, are now linked to serious eye problems beyond gout and kidney stones. Research ...

High uric acid can lead to painful gout, kidney stones, or even kidney dysfunction. Know everything about uric acid tests and why they are crucial for health.

Gout is the most common type of inflammatory arthritis. Eating foods like red meat, alcohol, and shellfish make the symptoms of gout worse.

San Diego-based Arthrosi Therapeutics, a biotech developing highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, flares, and dissolve tophi in gout and ...

US-based biotechnology company Arthrosi Therapeutics has completed a series E funding round, amassing $153m which is ...

Gout is an inflammatory form of arthritis that severely impacts patients’ functionality, quality of life and mobility. Credit: mapo_japan/Shutterstock.com. US-based biotechnology company Arthrosi ...

Hello, everyone. This is Guido Oelkers, CEO of Sobi. We are delighted to welcome you to this call to discuss the NASP program after we have just received the acceptance of the filing package with FDA ...

SAN DIEGO, Aug. 20, 2025 /PRNewswire/ -- Arthrosi Therapeutics, Inc., a late-stage biotechnology company advancing a potentially best-in-class, highly potent and selective next generation URAT1 ...

Overall, 59.4% of patients with gout receiving urate lowering therapy achieved remission at least once over 6 years, with rates increasing over time. Remission among patients with gout receiving urate ...

Gout flares are associated with cardiovascular events. Treating gout to target serum urate level prevents flares, but whether such treatment can also prevent cardiovascular events is unknown. An ...